The Effect of 360° Virtual Reality Movies on Fear and Anxiety (ENGAGE)

Maastricht Radiation Oncology

Status: Enrolling

Conditions: Fear; Breast Cancer; Brain Tumor; Lung Cancer; Head and Neck Cancer; Anxiety; Prostate Cancer

Treatments: Other: Questionnaire: QSC-R23; Other: Clinical data collected; Other: Questionnaire: HADS; Other: General questions; Other: Questionnaire: SPIRIT

Study type: Interventional

Funder types: Other

Identifiers

NCT06199050

ENGAGE

Details and patient eligibility

About

To assess the effect of web-based 360° Virtual Reality movies on fear and anxiety, The investigators would like to assess the patient-perceived level of fear and anxiety quantitatively, making use of several questionnaires.

Full description

In ENGAGE, a KWF Samenloop Voor Hoop subsidized project, we have developed VR movies to reduce fear and anxiety for patients who are going to be treated at Maastro. These movies are based on where most fear and anxiety are experienced and have been developed after extensive discussion with different disciplines in patient care and with agreement of the Director Patient Care. The movies include: 1) Mouldroom, 2) VMDIBH mamma photons, 3) Head and Neck photons, 4) Lung photons, 5) CT-scan, 6) Prostate photons, and 7) Head and Neck/ Neuro protons. Currently, the web-based 360° movies are implemented in clinical practice and the VR glasses with the 360° movies will be used as soon as social work has decided on where to integrate the use in the care pathway.

Enrollment: 600 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed with breast- (only VMDIP), lung-, prostate-, head and neck cancer, a brain tumor.
• Age 18+
• Being able to speak, read and write in Dutch
• General interview between radiation oncologist and patient (= Intake)
• Ability to give written informed consent before the start of the study
• Decision talk about start of treatment must have taken place

Exclusion criteria

• Patients who are already receiving radiotherapy treatment
• Pre-operative consultation for breast cancer patients
• Patients who have seen the VR-videos already

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

600 participants in 2 patient groups

360° Virtual Reality Movies

Experimental group

Description:

assess the amount of fear, anxiety and stress by using specific questionnaires: SPecifIc RadIation Treatment related questions (SPIRIT) Hospital Anxiety and Depression Scale (HADS) Dutch version of the Questionnaire on stress symptoms (QSC-R23) General questions: Education level Marietal status Medication use (in order to assess influence on fear) Previous cancer diagnosis Acquired information on treatment Expected fear and anxiety mitigation strategies Other cancer treatments (e.g. chemotherapy no, prior to RT, during RT, or after RT; surgery prior to or after RT) PROM at baseline Clinical data: Age Gender Cancer type WHO status TNM

Treatment:

Other: Questionnaire: SPIRIT

Other: General questions

Other: Questionnaire: HADS

Other: Clinical data collected

Other: Questionnaire: QSC-R23

Group without intervention

Experimental group

Description:

In a measurement over 5 months without any intervention the investigators have assessed the amount of fear, anxiety and stress by using a specific subjective questionnaire on the items below: assess the amount of fear, anxiety and stress by using specific questionnaires: SPecifIc RadIation Treatment related questions (SPIRIT) Hospital Anxiety and Depression Scale (HADS) Dutch version of the Questionnaire on stress symptoms (QSC-R23) General questions: Education level Marietal status Medication use (in order to assess influence on fear) Previous cancer diagnosis Acquired information on treatment Expected fear and anxiety mitigation strategies Other cancer treatments (e.g. chemotherapy no, prior to RT, during RT, or after RT; surgery prior to or after RT) PROM at baseline Clinical data: Age Gender Cancer type WHO status TNM

Treatment:

Other: Questionnaire: SPIRIT

Other: General questions

Other: Questionnaire: HADS

Other: Clinical data collected

Other: Questionnaire: QSC-R23